Dublin, Dec. 15, 2016 -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "DNA Sequencing - Technologies, Markets and Companies" to their offering.
This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them.
Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.
Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2015 is described with estimates for 2020 and 2025. Various methods and factors on which market estimates depend are described briefly. Markets are tabulated according to geographical areas as well as applications. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.
The report includes profiles of 137 companies involved in sequencing and their 145 collaborations. The report text is supplementd by 42 tables, 21 figures and 500 selected references to the literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. DNA Sequencing Technologies
3. Role of Bioinformatics in Sequencing
4. Comparative Analysis of Sequencing Technologies
5. Sequencing for Research
6. Applications of Sequencing in Healthcare
7. Applications of Sequencing in Oncology
8. Sequencing in Genetic Disorders
9. Sequencing in Neurological and Psychiatric Disorders
10. Applications of sequencings in infections
11. Role of Sequencing in Personalized Medicine
12. Current Status and Future Prospects
13. Markets for Sequencers
14. Companies Involved in Sequencing
15. References
For more information about this report visit http://www.researchandmarkets.com/research/r6zngl/dna_sequencing
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics


CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Apple Turns 50: From Garage Startup to AI Crossroads
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
First Western Ship Transits Strait of Hormuz Since Iran War Began
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 



